Tin tức thị trường
12.11.2024

Company news: AstraZeneca’s (AZN) quarterly results beat analysts’ forecasts

AstraZeneca (AZN) reported Q3 FY2024 earnings of $2.08 per share (versus $1.73 per share in Q3 FY2023), beating analysts’ consensus estimate of $2.04 per share.

The company’s quarterly revenues amounted to $13.565 bln (+18.0% y/y), beating analysts’ consensus estimate of $13.076 bln.

AZN fell to $64.00 (-1.22%) in pre-market trading.

Xem thêm